Skip to main content

Table 3 Protein carbonylation profile by comparison of No treatment and FA treatment of HepG2

From: Hepatic protein Carbonylation profiles induced by lipid accumulation and oxidative stress for investigating cellular response to non-alcoholic fatty liver disease in vitro

Spot No.

Protein ID

Protein name

2DE

Prediction

Mascot score

Sequence coverage

Log2 Ratio*

MW(kDa)

pI

MW(kDa)

pI

16

P00338

L-lactate dehydrogenase A chain isoform 3

39

8.6

36.6

8.44

1732

80.1

0.00

34

P04057

Fructose-bisphosphate aldolase A isoform 1

48

7.7

13.2

8.52

2058

86.5

− 1.36

35

P78330

Phosphoserine phosphatase

29

5.5

25

5.51

1246

84

0.00

36

P35270

Sepiapterin reductase

28

8.7

28.0

8.2

820

67

−3.47

37

P11021

78 kDa glucose-regulated protein

86

4.3

72.3

5.0

277

12

−1.65

38

P68371

Tubulin beta-4B chain

66

3.6

49.8

4.7

2177

83.4

−1.43

39

Q9Y3F4

Serine-threonine kinase receptor-associated protein

46

4.1

38.4

4.9

56

5

−2.06

40

P55735

Protein SEC13 homolog

43

4.4

35.5

5.2

88

19

−1.03

41

Q13733

Sodium/potassium-transporting ATPase subunit alpha-4

40

4.9

114.1

6.2

29

2

0.00

42

Q15181

Inorganic pyrophosphatase

38

5.6

32.6

5.5

309

35

−2.19

43

Q9HC38

Glyoxalase domain-containing protein 4

36

5.2

34.7

5.4

31

4

0.00

44

P08758

Annexin A5

36

4.0

35.9

4.9

1419

58

−1.29

45

P12004

Proliferating cell nuclear antigen

37

3.4

28.7

4.5

406

62

−1.29

46

Q15691

Microtubule-associated protein RP/EB family member 1

35

4.3

29.9

5.0

60

27

−1.74

47

Q99943

1-acyl-sn-glycerol-3-phosphate acyltransferase alpha

30

4.4

31.7

9.48

38

3

−1.43

48

P35232

Prohibitin

31

5.6

29.8

5.5

1199

59

−1.84

49

P29401

Transketolase

74

8.5

67.8

7.5

791

41

−3.47

50

Q9UL46

Proteasome activator complex subunit 2

32

5.1

27.4

5.5

723

74

0.00

51

P25705

ATP synthase subunit alpha, mitochondrial

31

9.4

59.7

5.1

1222

42.7

−1.58

  1. * Log2 Ratio refers to Log2 ratio of spot intensity from FA treatment to No treatment